TP53 and COVID-19: In keeping with the capacity of IFNs to increase apoptosis and facilitate lung tissue damage (Broggi et al., 2020a; Major et al., 2020), gene enrichment also revealed that the p53 pathway is significantly upregulated in COVID-19 patients (Figures 5A and 5C).